Soligenix
ID: 5313094Soligenix is a Princeton, New Jersey-based developer of biodefense vaccines and therapeutics for the side-effects of cancer treatment and gastrointestinal diseases.
2
Funding Rounds
$6.7m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Ch********* J. Sc***** | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Ch********* J. Sc***** | - | - | |
| Di*** Pa*** | - | - | - |
| Gr*** A. La****** |
|
- | |
| Je**** B. Ze**** | - | - |
Funding
Funding series
Funding Series Analysis
The company Soligenix has raised a total of $6.66m in funding over 2 rounds.
Key Insights:
- Soligenix seed round: $1.5m
- Soligenix funding round, June 2010: $5.16m
Soligenix seed round
$1.5m
Industries
Soligenix is active in the following industries: